English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

ated in each group, TST and SST Z-scores of HBeAg-positive patients were significantly higher than those in anti-HBe positive patients in group 1 ( p < 0.05). No statistically significant differences were observed in the other Z-scores ( p > 0.05). When HBeAg-positive patients and antiHBe-positive patients were compared in group 2, TST, SST, MAC, and MAMA Z-scores were not found to be statistically different ( p > 0.05; Table 1 ). Also, no correlation A total of 43 children with chronic hepatitis B aged from 2 to 17 years were tested for anthropometric measurements such as weight, height, mid-arm circumference (MAC), mid-arm muscle area (MAMA), body mass index, triceps skin-fold thickness and subscapular skin-fold thickness (SST) every month following initiation of treatment for this condition. When the initial pretreatment anthropometric measurements of both groups (patients whom only interferon-α (IFN-α) given and patients whom combination treatment given) were compared, no statistically significant difference was observed in terms of height, weight, body mass index, MAC, SST, and MAMA Z-scores ( p > 0.05). Thirteen patients had malnutrition (30%) and 16% of them had obesity. When the association between the HBeAg-positive and anti-HBe-positive patients and the anthropometric measurements at the end of the treatment were evaluReceived: May 1, 2017 Accepted: June 5, 2017 Published online: June 17, 2017

Effect of Interferon-α and Combined Interferon-α with Lamivudine Treatment on Anthropometric Measurements in Children with Chronic Hepatitis B